Company Filing History:
Years Active: 2014
Title: Innovations of Aleksander Kadushkin
Introduction
Aleksander Kadushkin is a notable inventor based in Zheleznodorozhnyi, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate tyrosine kinase activity. With a total of 2 patents to his name, Kadushkin's work is recognized for its potential impact on treating various diseases.
Latest Patents
Kadushkin's latest patents include innovative compounds designed to inhibit tyrosine kinase activity. The first patent provides compounds of the formula (I), or a stereoisomer, tautomer, salt, hydrate, or prodrug thereof, that modulate tyrosine kinase activity, along with compositions comprising these compounds and methods of their use. The second patent focuses on heterocyclic compounds that are useful in treating neoplastic diseases, inflammatory disorders, and immunomodulatory disorders. This invention also provides compounds capable of modulating tyrosine kinases, along with compositions and methods for their application.
Career Highlights
Kadushkin is currently associated with Chembridge Corporation, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges through scientific discovery.
Collaborations
Throughout his career, Kadushkin has collaborated with esteemed colleagues, including Vlad Edward Gregor and Yahua Liu. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical field.
Conclusion
Aleksander Kadushkin's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work in developing tyrosine kinase inhibitors showcases the potential for advancements in treating various diseases.